Metabolic syndrome (MetS) is considered a cluster of multiple interrelated metabolic disorders, including obesity, insulin resistance, dyslipidemia, hypertension, and hyperglycemia[@b1][@b2]. MetS has gained importance because of its close association with type 2 diabetes and cardiovascular disease[@b3][@b4]. It has been well documented that adiposity and insulin resistance are strongly associated with the development of MetS in the general population[@b5][@b6]. Obesity is highly correlated with insulin resistance; thus, it may play a key role as an initiating factor in the development of MetS[@b3][@b7]. Evidence from epidemiological studies has indicated that the origins of chronic diseases, including type 2 diabetes and MetS, begin early in life, even in utero[@b8], and both childhood adiposity and insulin resistance are well-established risk factors for adult diabetes, MetS and cardiovascular disease[@b9][@b10][@b11]. Investigation of the childhood origins of MetS has implications for preventive measures of MetS in early life.

It has been proposed that the association between obesity and MetS is more than merely a dose-response relationship[@b12][@b13][@b14]. Insulin resistance is considered a key link between obesity and type 2 diabetes or MetS. Recent studies have demonstrated that some obese adults and children with higher insulin sensitivity exhibit a relatively better metabolic profile compared to those with insulin-resistant obesity[@b15][@b16][@b17][@b18][@b19]. Longitudinal studies have indicated that insulin-sensitive obese individuals may be protected from increased risk of type 2 diabetes and cardiovascular disease[@b16][@b20][@b21]. Furthermore, studies have shown that the presence of metabolic disorders varies widely among obese individuals as a function of differences in the degree of insulin sensitivity[@b12][@b18][@b22]. Despite extensive observations on insulin-resistant and sensitive obesity, information is scant regarding whether the association between childhood adiposity and MetS in later life is dependent on insulin resistance. In the current study, we aimed to test the hypothesis that the effect of early-life adiposity on the development of MetS is modified by insulin resistance in childhood in a longitudinal cohort from the Bogalusa Heart Study.

Results
=======

[Table 1](#t1){ref-type="table"} summarizes the mean levels of study variables in childhood and adulthood by race and gender. In childhood, age and BMI did not significantly differ between races or genders. There were significant race differences in childhood glucose (whites \> blacks) and insulin levels (blacks \> whites). Gender differences were also significant in childhood glucose (boys \> girls) and insulin levels (girls \> boys). Black children had higher HOMA values than white children (2.5 vs. 2.3, p = 0.006). In adulthood, blacks had higher levels of BMI, glucose, insulin, blood pressure, HOMA, and HDL-C, and lower levels of triglycerides than whites. Black women had higher WC than white women, but white men had higher WC than black men. At follow-up, the prevalence of MetS did not show a significant race difference (18.2% in blacks vs. 23.0% in whites, p = 0.127).

[Figure 1](#f1){ref-type="fig"} shows odds ratios (OR) for the associations of childhood BMI, glucose, insulin and HOMA levels with adult MetS by race. After adjusting for age, gender, and follow-up years, childhood BMI, insulin (log-transformed) and HOMA (log-transformed) all showed significant associations with adult MetS in blacks and whites, but childhood glucose did not show a significant association. There were no race differences in ORs for the associations of childhood BMI, glucose, insulin and HOMA with adult MetS (all p \> 0.05).

As shown in [Supplement Table S1](#S1){ref-type="supplementary-material"}, childhood log-HOMA was significantly associated with adult overweight/obesity (OR = 1.70, p \< 0.001), hyperglycemia (OR = 1.35, p = 0.001), high blood pressure (OR = 1.28, p \< 0.001) and dyslipidemia (OR = 1.23, p \< 0.001), adjusting for baseline age, race, gender, and follow-up years.

Mean levels of study variables by levels of childhood BMI and HOMA values are shown in [Table 2](#t2){ref-type="table"}. After adjusting for age, race, gender and follow-up years, high levels of childhood BMI and HOMA were significantly associated with higher levels of adult MetS variables, including BMI, WC, insulin, blood pressure, HOMA, and prevalence of MetS. The insulin-resistant obesity group had significantly higher levels of BMI, WC, insulin, and systolic blood pressure in adulthood than the insulin-sensitive obesity group, adjusting for race, gender, childhood age and follow-up years. Adult levels of HOMA and diastolic blood pressure were marginally higher in the insulin-resistant obesity group than in the insulin-sensitive obesity group, but serum glucose, HDL-C, and triglycerides in adulthood did not showed significant difference between the two groups. Of note, prevalence of MetS was significantly higher in the insulin-resistant obesity group than the insulin-sensitive obesity group (34.9% vs. 24.3%, p = 0.008).

Multivariable-adjusted ORs for the association between childhood insulin-resistant adiposity and adult MetS, using insulin-sensitive adiposity as a reference, are presented in [Table 3](#t3){ref-type="table"}. Individuals with insulin-resistant obesity were 1.7 times (p = 0.011) more likely to have MetS than those with insulin-sensitive obesity, after adjustment for baseline age, race, gender, and follow-up years. The ORs did not differ significantly (p = 0.724 for race difference) between whites (OR = 1.72, p = 0.026) and blacks (OR = 1.63, p = 0.206). The follow-up period ranged from 5.0 to 33.8 years. Logistic regression models performed by tertile of follow-up years yielded ORs (95% CIs) that were 2.50 (1.00--7.15), 1.75 (0.86--3.72) and 1.47 (0.81--2.67) in the first, second and third tertile of follow-up years (5.0--14.6, 14.7--23.6 and 23.7--33.8 years), respectively. The ORs did not differ significantly between groups.

The multivariable-adjusted ORs for the association between adult MetS and childhood insulin-resistant and insulin-sensitive adiposity, defined by insulin or glucose levels, are shown in [Supplement Table S2](#S1){ref-type="supplementary-material"}. Individuals with childhood adiposity who also had high insulin levels were 1.53 times (p = 0.036) more likely to have MetS than those with childhood adiposity who had lower insulin levels; the association did not differ between whites (OR = 1.68, p = 0.032) and blacks (OR = 1.20, p = 0.636). In contrast, childhood adiposity with high glucose levels was not associated with adult MetS.

[Figure 2](#f2){ref-type="fig"} shows the ORs for the association of childhood BMI tertiles with adult MetS by childhood HOMA levels (tertiles). Of note, the OR values for the association of childhood BMI with adult MetS significantly increased across the increasing tertiles of childhood HOMA levels (OR = 1.73 in tertile I, OR = 2.18 in tertile II, OR = 3.45 in tertile III, p \< 0.001 for trend). The significant increasing trend in ORs reflects the interaction between childhood adiposity and insulin resistance on the subsequent occurrence of adult MetS. Additionally, the interaction effect of childhood BMI with HOMA on adult MetS was also significant (p = 0.006) using HOMA as a continuous variable, which was substantially similar to the interaction effect using HOMA tertiles.

Discussion
==========

Obesity and insulin resistance are well-known risk factors for MetS in children and adults[@b9][@b23][@b24]. By investigating the childhood origins of MetS, future preventive measures in early life can be appropriately targeted. We have previously reported that childhood BMI and insulin predict adulthood MetS[@b25]. However, previous data did not examine the role of insulin resistance in the relationship between adiposity in early life and the development of MetS in later life. In the current study, individuals with insulin-resistant obesity in childhood were more likely to develop adult MetS than those with insulin-sensitive obesity in childhood. This study provides strong evidence that the effect of childhood adiposity on the development of adult MetS is modified by insulin resistance in childhood. These observations suggest that in the presence of insulin-resistance, the association between childhood adiposity and MetS in later life is strengthened.

Childhood adiposity has been observed to track into adulthood, and is recognized as a predictor of MetS in later life[@b26][@b27]. In a review of 11 studies investigating the association between childhood BMI and adult metabolic risk, childhood adiposity was positively associated with total cholesterol, LDL-C, triglyceride and insulin concentration in adulthood[@b28]. Three studies reported positive correlations between childhood BMI and the number of MetS criteria and risk of developing MetS in adulthood[@b11][@b25][@b29]. Morrison *et al.* reported that the OR for developing MetS in adulthood was 1.03 with each one unit increase in childhood BMI percentile[@b29]. We noted in this study that early life adiposity along with higher insulin and HOMA levels during childhood was strongly associated with increased risk of MetS in adulthood.

Insulin resistance is closely associated with obesity and considered to play a pathogenic role in MetS[@b24][@b30]. A subset of obese individuals are often described as metabolically healthy obese and are characterized by high insulin sensitivity which may protect them to some extent against obesity-related metabolic complications[@b13]. Vukovic *et al.* reported that obese children who were insulin-sensitive have significantly "healthier" metabolic profiles compared to their insulin-resistant peers in a group of 248 children and adolescents[@b19]. Karelis and colleagues reported insulin-sensitive obese individuals had a lower levels of inflammatory markers compared with those with insulin resistance among 88 obese postmenopausal women[@b14]. Longitudinal studies have also suggested that these individuals have a lower risk of type 2 diabetes and cardiovascular disease than their insulin-resistant counterparts[@b16][@b20]. In the present study, we found that prevalence of adult MetS was significantly higher in the insulin-resistant obesity group than in the insulin-sensitive obesity group. This study expands previous findings by demonstrating that the relationship between childhood obesity and adult MetS is modified by childhood insulin resistance. In the current study, we found that individuals with insulin-resistant obesity in childhood were 1.7 times more likely to have MetS 19 years later on average than those with insulin-sensitive obesity. More importantly, the strength of the association significantly increased across increasing tertiles of childhood HOMA values.

In addition, we found that blacks had higher HOMA than whites during childhood and adulthood in the present study; however, the strength of the association between childhood BMI and adult MetS across levels of childhood HOMA values did not differ between races. To the best of our knowledge, this is one of the first studies to examine the childhood origins of adult MetS in black and white individuals and further examines the interplay of adiposity and insulin resistance. Our data indicated that insulin resistance amplified the association between childhood adiposity and adult MetS equally in both races. These observations across race groups should be confirmed and replicated in other population studies.

There are several putative mechanisms linking childhood obesity and insulin resistance to MetS in later life. First, obesity tends to persist from childhood into adulthood. The Bogalusa Heart Study and other studies have found that the tracking of obesity across the lifespan contributed to a higher risk of metabolic disorders in adulthood[@b28][@b31]. This tracking phenomenon may contribute to the association between childhood obesity and adult MetS. Second, obese individuals with insulin resistance might have additional predisposing factors as compared to insulin-sensitive obese individuals, for example higher lipid deposition in intramyocellular and visceral compartments and lower adiponectin levels[@b15][@b32]. Under these conditions, insulin resistance may amplify adverse effects of childhood adiposity on metabolic profile in adulthood. Third, genetic susceptibility may contribute to the interplay of obesity and insulin resistance on the development of MetS. Previous studies have indicated that decreased expression of genes involved in glucose uptake and lipogenesis in adipose tissue was associated with insulin-resistant obesity[@b33][@b34][@b35].

This community-based, longitudinal cohort provided a unique opportunity to test the effect insulin-resistance on the relationship between early-life adiposity and the development of MetS in adulthood. The present study has some limitations. First, categorizing childhood adiposity and insulin resistance as the upper 55^th^ percentile of BMI and HOMA, respectively, seems broad. The relatively small sample size and consequently limited statistical power was the primary consideration for the selection of the cut-off values. In sensitivity analyses using a cut-off value of 75^th^ percentile and above for BMI and HOMA, ORs remained statistically significant. Second, the follow-up period of the study subjects varied from 5 to 34 years. The wide range of follow-up time might have an influence on the obesity/insulin resistance-MetS association. The number of follow-up years was, therefore, included in all logistic models for adjustment in the current analysis. Moreover, we conducted additional analysis by tertiles of follow-up year and did not find a significant difference in ORs between groups.

In conclusion, we demonstrated that childhood adiposity with insulin resistance was associated with an increased risk of MetS in later life as compared to those with insulin-sensitive obesity in childhood. In particular, ORs for the association of childhood BMI with adult MetS significantly increased with across tertiles of childhood HOMA. This significant increasing trend reflects the impact of insulin resistance on the relationship between childhood adiposity and adult MetS. These results support the notion that the long-term impact of childhood adiposity on the development of MetS in later life begins in childhood, and is further amplified by insulin resistance. These findings underscore the importance of controlling both adiposity and insulin resistance in early life for the prevention of MetS later in life.

Methods
=======

Study cohort
------------

The Bogalusa Heart Study is a series of long-term studies in a semi-rural biracial (65% white and 35% black) community in Bogalusa, Louisiana begun in 1973 by Dr. Gerald Berenson, focusing on the early natural history of cardiovascular disease since childhood. Between 1973 and 2010, nine cross-sectional surveys of children aged 4--19 years and ten cross-sectional surveys of adults aged 19--50 years who had been previously examined as children were conducted in Bogalusa. Linking these repeated cross-sectional examinations conducted every 2--3 years has resulted in serial observations during childhood. A total of 1,593 adult subjects (1,032 whites and 561 blacks; 42.6% males; age range = 19--50 years; mean age = 31.5 years at follow-up) who were examined for MetS variables as both children and adults, with a mean follow-up period of 19.2 years (range = 5.0--33.8 years), were included in the present analysis. For individuals who participated in multiple screenings as children and adults, data from the earliest childhood and most recent adulthood examination were used to maximize the follow-up interval. All subjects in this study gave informed consent at each examination, and for those under 18 years of age, consent of a parent/guardian was obtained. Study protocols were approved by the Institutional Review Board of the Tulane University Health Sciences Center. The methods were carried out in accordance with the approved guidelines.

General examinations
--------------------

Standardized protocols were used by trained examiners across all surveys since 1973[@b36]. Subjects were instructed to fast for 12 hours before screening. Body mass index (BMI, weight in kilograms divided by the square of the height in meters) was used as a measure of adiposity. The waist circumference was measured midway between the rib cage and the superior border of the iliac crest while subjects were standing. Blood pressure levels were measured between 8:00 AM and 10:00 AM on the right arm of subjects in a relaxed, sitting position by 2 trained observers (3 replicates each). Systolic and diastolic (4th Korotkoff phase for children and 5th Korotkoff phase for adults) blood pressure was recorded using a mercury sphygmomanometer[@b37]. The mean values of the 6 readings were used for analysis. Three measurements were obtained with a nonstretchable tape, and the mean value was used for analysis.

Laboratory analyses
-------------------

Serum triglycerides (TG) levels were assayed using enzymatic procedures on a Hitachi 902 Automatic Analyzer (Roche Diagnostics, Indianapolis, IN). Serum lipoprotein cholesterol levels were analyzed by a combination of heparin-calcium precipitation and agar-agarose gel electrophoresis procedures. A commercial radioimmunoassay kit was used for measuring plasma immunoreactive insulin levels (Phadebas; Pharmacia Diagnostics, Piscataway, NJ). Plasma Glucose levels were measured as part of a multiple chemistry profile (SMA20; Laboratory Corporation of America, Burlington, NC) by a glucose oxidase method. Insulin resistance status was assessed using the homeostasis model assessment of insulin resistance (HOMA) according to the formula described previously: HOMA = insulin (μU/mL) × glucose (mmol/L)/22.5.

Statistical methods
-------------------

All statistical analyses were performed with SAS version 9.3 (SAS Institute, Cary, NC). Adult MetS was defined according to NCEP ATPIII guidelines[@b38]. These criteria included: 1) abdominal obesity (waist circumference ≥102 cm for men and ≥88 cm for women), 2) hypertriglyceridemia (fasting triglycerides ≥ 150 mg/dL), 3) low HDL cholesterol (\<40 mg/dL for men and \<50 mg/dL for women, or taking cholesterol lowering medication), 4) high blood pressure (≥130/85 mmHg or taking antihypertensive medication), and 5) high fasting glucose (≥100 mg/dL or taking antidiabetic medication) (24). Childhood fasting glucose and insulin values were used to calculate HOMA. Childhood adiposity and insulin resistance were defined as being above 55^th^ percentile of BMI and HOMA, respectively, with 10% of children in the middle (46^th^ -- 55^th^ percentile) excluded to make the groups more distinct. The exclusion of this 10% of children for BMI and HOMA values resulted in an exclusion of 19.1% of the total sample. Accordingly, the remaining cohort was divided into 4 groups: group I (BMI↓/HOMA↓), group II (BMI↓/HOMA↑), group III (BMI↑/HOMA↓), and group IV (BMI↑/HOMA↑). The prevalence of adult MetS was compared between the childhood insulin-sensitive obesity group (group III, n = 235) and the childhood insulin-resistant obesity group (group IV, n = 416). Analyses of covariance were performed using general linear models (GLM) to test differences in study variables between race, gender and adiposity groups. Multivariable logistic regression models were used to examine the association between adult MetS and insulin-resistant obesity, adjusted for baseline age, race, gender, and follow-up years. The modification effect of childhood insulin resistance on the BMI-MetS association was examined by logistic regression interaction models using the entire sample. Because the wide range of follow-up years might have an impact on ORs for the association between obesity/insulin resistance and MetS, logistic regression models were also performed by tertile of follow-up years.

Additional Information
======================

**How to cite this article**: Zhang, H. *et al.* Long-term Impact of Childhood Adiposity on Adult Metabolic Syndrome Is Modified by Insulin Resistance: The Bogalusa Heart Study. *Sci. Rep.* **5**, 17885; doi: 10.1038/srep17885 (2015).

Supplementary Material {#S1}
======================

###### Supplementary Information

This study was supported by grants ES-021724 from National Institute of Environmental Health Sciences and AG-16592 and AG-041200 from the National Institute on Aging. Drs. Huijie Zhang and Tao Zhang were supported by grants from China Natural Science Foundation (81570785 and 81302514).

**Author Contributions** H.Z., T.Z. and W.C. generated the hypothesis, directed implementation, and wrote the manuscript. S.L., Y.L. and A.H. contributed to analytic strategy and statistical analyses. Authors C.F., E.H., L.A.B. and J.H. supervised the field activities and data collection and edited the manuscript.

![Odds ratio (OR) for the association of childhood BMI, glucose, insulin and HOMA with adult MetS by race, adjusted for covariates of age, gender, follow-up years or race.\
HOMA = homeostasis model assessment of insulin resistance; BMI = body mass index.](srep17885-f1){#f1}

![Odds ratio for the association of childhood BMI tertiles with adult MetS by childhood HOMA tertile groups, adjusted for covariates age, race, gender, and follow-up years.\
HOMA = homeostasis model assessment of insulin resistance. BMI = body mass index.](srep17885-f2){#f2}

###### Population characteristics in childhood and adulthood by race and gender.

                                                            Whites            Blacks      P-values[a](#t1-fn1){ref-type="fn"}                           
  --------------------------------------------------- ------------------- -------------- ------------------------------------- -------------- --------- ---------
  Sample size                                                 458              574                        220                       341                      
  Childhood                                                                                                                                             
   Age (year)                                             12.3 (3.6)        11.8 (3.5)                11.8 (3.8)                 11.8 (3.8)     0.012     0.991
   BMI (kg/m^2^)                                          19.5 (4.1)        19.0 (4.3)                19.1 (4.5)                 19.4 (4.4)     0.966     0.146
   Glucose (mg/dL)                                      84.8 (7.1)\*\*      82.6 (7.6)              83.1 (9.1)\*\*               80.9 (8.4)     0.015     0.001
   Insulin (μU/mL)                                      10.4 (7.0)\*\*      11.4 (7.9)               11.0 (9.5)\*                13.0 (8.7)     0.114     0.003
   HOMA                                                   2.2 (1.6)\*       2.4 (1.7)                  2.3 (2.2)                 2.6 (1.9)      0.207     0.017
  Adulthood                                                                                                                                             
   Age (year)                                             31.9 (8.0)        31.3 (8.1)                30.2 (8.8)                 30.4 (8.1)     0.012     0.091
   Follow-up years                                        19.6 (7.1)        19.5 (7.0)                18.5 (7.7)                 18.6 (7.4)     0.054     0.049
   WC (cm)                                              96.4 (17.1)\*\*    85.2 (17.8)                92.1 (18.9)               91.1 (18.4)     0.033    \<0.001
   BMI (kg/m^2^)                                         28.4 (6.2)\*       27.4 (7.7)              28.6 (7.4)\*\*               30.4 (8.4)     0.237    \<0.001
   Glucose (mg/dL)[b](#t1-fn2){ref-type="fn"}           85.9 (15.1)\*\*     81.7 (9.8)              88.9 (24.7)\*\*             84.0 (16.6)     0.003     0.001
   Insulin (μU/mL)[b](#t1-fn2){ref-type="fn"}             12.0 (9.3)        11.4 (8.7)               12.4 (9.3)\*               14.5 (10.0)     0.378    \<0.001
   HOMA[b](#t1-fn2){ref-type="fn"}                         2.6 (2.4)        2.4 (2.1)                  2.9 (2.7)                 3.1 (2.4)      0.078    \<0.001
   Systolic BP(mmHg)[b](#t1-fn2){ref-type="fn"}        115.3 (10.4)\*\*    107.6 (9.5)             119.6 (15.0)\*\*             111.8 (11.7)   \<0.001   \<0.001
   Diastolic BP(mmHg)[b](#t1-fn2){ref-type="fn"}        77.5 (8.5)\*\*      72.7 (8.0)              78.1 (12.2)\*\*              74.1 (9.8)     0.006     0.001
   HDL-C (mg/dL)[b](#t1-fn2){ref-type="fn"}             42.0 (11.0)\*\*    49.0 (12.5)                51.8 (16.2)               53.2 (14.2)    \<0.001   \<0.001
   Triglycerides (mg/dL)[b](#t1-fn2){ref-type="fn"}    141.9 (111.3)\*\*   111.2 (66.5)            109.1 (81.1)\*\*             80.9 (37.1)     0.001    \<0.001
   MetS, n (%)                                            118 (25.8)        119 (20.7)                 45 (20.5)                 57 (16.7)      0.349     0.290

Continuous variables are presents as means (SD).

BMI = body mass index; HOMA = homeostasis model assessment of insulin resistance; WC = Waist circumference; BP = blood pressure; HDL-C = high-density lipoprotein cholesterol; MetS = metabolic syndrome.

Gender difference: \*p \< 0.05; \*\*p \< 0.01.

^a^P-values for race difference in continuous MetS variables were adjusted for age.

^b^Individuals who took medications were excluded.

###### Group characteristics by levels of childhood BMI and HOMA.

                                                       Groups by levels of childhood BMI and HOMA[a](#t2-fn1){ref-type="fn"}   P-Value[†](#t2-fn3){ref-type="fn"}   P-Value[‡](#t2-fn4){ref-type="fn"}                           
  --------------------------------------------------- ----------------------------------------------------------------------- ------------------------------------ ------------------------------------ -------------- --------- ---------
  Sample size                                                                           398                                                   239                                  235                       416                      
   Whites/Blacks                                                                      263/135                                                149/90                               146/89                   276/140       0.554     0.319
   Males/Females                                                                      174/224                                               101/138                               87/148                   184/232       0.303     0.087
  Childhood                                                                                                                                                                                                                           
   Age (year)                                                                       12.4 (3.6)                                             12.5 (3.4)                           12.1 (3.9)                11.9 (3.5)     0.064     0.393
   BMI (kg/m^2^)                                                                    16.7 (2.0)                                             17.0 (2.0)                           21.1 (3.7)                22.9 (4.9)    \<0.001   \<0.001
   Glucose (mg/dL)                                                                  80.8 (7.3)                                             85.6 (8.5)                           80.1 (7.6)                85.1 (7.4)    \<0.001   \<0.001
   Insulin (μU/mL)                                                                   6.3 (2.2)                                             15.6 (7.6)                           6.7 (2.5)                 17.9 (9.8)    \<0.001   \<0.001
   HOMA                                                                              1.3 (0.4)                                             3.3 (1.7)                            1.3 (0.5)                 3.8 (2.2)     \<0.001   \<0.001
  Adulthood                                                                                                                                                                                                                           
   Age (year)                                                                       31.1 (8.2)                                             32.7 (8.1)                           31.2 (8.3)                31.5 (8.2)     0.093     0.661
   Follow-up years                                                                  18.7 (7.2)                                             20.2 (7.7)                           19.1 (7.1)                19.7 (7.3)     0.056     0.349
   WC (cm)                                                                          82.6 (14.4)                                           83.8 (14.3)                          95.4 (18.3)               101.6 (19.2)   \<0.001   \<0.001
   BMI (kg/m^2^)                                                                    24.7 (5.2)                                             25.0 (5.0)                           31.3 (7.4)                33.5 (8.1)    \<0.001   \<0.001
   Glucose (mg/dL)[b](#t2-fn2){ref-type="fn"}                                       81.9 (9.8)                                            84.9 (18.6)                          85.5 (20.0)               86.5 (18.1)    \<0.001    0.656
   Insulin (μU/mL)[b](#t2-fn2){ref-type="fn"}                                        9.3 (5.9)                                             11.0 (7.8)                          14.0 (12.1)               15.8 (10.8)    \<0.001    0.049
   HOMA[b](#t2-fn2){ref-type="fn"}                                                   1.9 (1.5)                                             2.5 (2.3)                            3.1 (2.9)                 3.5 (2.8)     \<0.001    0.062
   Systolic BP(mmHg)[b](#t2-fn2){ref-type="fn"}                                    110.8 (11.0)                                           112.0 (10.9)                         112.3 (11.3)              114.8 (13.2)   \<0.001    0.031
   Diastolic BP(mmHg)[b](#t2-fn2){ref-type="fn"}                                    74.2 (8.6)                                             75.2 (9.1)                           75.1 (8.5)               76.8 (10.6)    \<0.001    0.090
   HDL-C (mg/dL)[b](#t2-fn2){ref-type="fn"}                                         49.7 (14.1)                                           51.3 (14.5)                          48.0 (13.5)               45.6 (13.2)    \<0.001    0.127
   Triglycerides (mg/dL)[b](#t2-fn2){ref-type="fn"}                                100.3 (74.9)                                           107.6 (70.5)                         113.9 (84.8)              125.2 (86.1)   \<0.001    0.341
   MetS, n (%)                                                                       45 (11.3)                                             35 (14.6)                            57 (24.3)                 145 (34.9)    \<0.001    0.008

Continuous variables are presents as means (SD).

BMI = body mass index; HOMA = homeostasis model assessment of insulin resistance; WC = Waist circumference; BP = blood pressure; HDL-C = high-density lipoprotein cholesterol; MetS = metabolic syndrome.

^a^Low and high levels of childhood BMI and HOMA were defined as bottom and top 45^th^ percentiles, respectively.

^b^Individuals who took medications were excluded.

^†^P-values for difference in continuous MetS variables among 4 groups were adjusted for race, gender, and age.

^‡^P-values for difference in continuous MetS variables between groups III and IV were adjusted for race, gender, and age.

###### Association between childhood insulin-resistant adiposity and adult MetS, adjusting for covariates in logistic regression models.

                                           Using childhood insulin-sensitive adiposity as a reference                                                                           
  --------------------------------------- ------------------------------------------------------------ ------------ --------- ------ ------------ --------- ------ ------------ ---------
  Black race                                                          ---                                  ---         ---     ---       ---         ---     0.69   0.46--1.03    0.074
  Female sex                                                          0.55                              0.35--0.86    0.008    0.63   0.31--1.30    0.213    0.57   0.39--0.83    0.003
  Childhood age                                                       1.07                              1.00--1.14    0.041    1.16   1.06--1.28    0.002    1.10   1.05--1.16   \<0.001
  Follow-up years                                                     1.13                              1.09--1.17   \<0.001   1.15   1.10--1.21   \<0.001   1.14   1.11--1.17   \<0.001
  Childhood insulin-resistant adiposity                               1.72                              1.08--2.80    0.026    1.63   0.77--3.56    0.206    1.69   1.13--2.54    0.011

OR = odds ratio; CI = confidence interval.

[^1]: These authors contributed equally to this work.
